• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华东地区溶酶体贮积症亚型的人口统计学特征和分布。

Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.

机构信息

Paediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Hum Genet. 2016 Apr;61(4):345-9. doi: 10.1038/jhg.2015.155. Epub 2016 Jan 7.

DOI:10.1038/jhg.2015.155
PMID:26740238
Abstract

Lysosomal storage disorders (LSDs) are a group of >50 different types of inherited metabolic disorders that result from defects in the lysosome. The aim of this study was to investigate the distribution and demographic characteristics of the different subtypes of LSDs in Eastern China. From 2006 to 2012, 376 out of 1331 clinically suspected patients were diagnosed with 17 different subtypes of LSDs at our hospital. Mucopolysaccharidoses (MPS) were the most common group of LSDs (50.5%), followed by sphingolipidoses (25.4%) and Pompe disease (19.8%). Mucolipidosis type II/III accounted for the remaining 4% of diagnosed LSDs. MPS II was the most common form of MPS, comprising 47.4% of all MPS cases diagnosed, followed by MPS IVA (26.8%) and MPS I (16.3%). Gaucher disease and Niemann-Pick disease type A/B were the two most common forms of sphingolipidoses. There was a large variation in the time between disease onset and eventual diagnosis, from 0.3 years in infantile-onset Pompe disease to 30 years in Fabry disease, highlighting timely and accurate diagnosis of LSDs as the main challenge in China.

摘要

溶酶体贮积症(LSDs)是一组由 50 多种不同类型的遗传性代谢紊乱引起的疾病,这些疾病是由于溶酶体的缺陷所致。本研究旨在调查中国东部地区不同 LSD 亚型的分布和人口统计学特征。2006 年至 2012 年,我院共诊断出 17 种不同亚型的 LSDs,其中 376 例来自于 1331 例临床疑似患者。黏多糖贮积症(MPS)是最常见的 LSD 组(50.5%),其次是鞘脂贮积症(25.4%)和庞贝病(19.8%)。黏脂贮积症 II/III 占诊断出的 LSDs 的其余 4%。MPS II 是最常见的 MPS 形式,占所有 MPS 病例的 47.4%,其次是 MPS IVA(26.8%)和 MPS I(16.3%)。戈谢病和尼曼-匹克病 A/B 是两种最常见的鞘脂贮积症形式。从婴儿型庞贝病的发病到最终诊断的时间差异很大,从 0.3 年到 30 年不等,这突出了 LSDs 的及时和准确诊断是中国面临的主要挑战。

相似文献

1
Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.华东地区溶酶体贮积症亚型的人口统计学特征和分布。
J Hum Genet. 2016 Apr;61(4):345-9. doi: 10.1038/jhg.2015.155. Epub 2016 Jan 7.
2
Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease.溶酶体贮积症:庞贝病、法布雷病、戈谢病和黏多糖贮积症大型印度患者队列中的新的和常见的致病性变异体。
Clin Biochem. 2021 Mar;89:14-37. doi: 10.1016/j.clinbiochem.2020.12.002. Epub 2020 Dec 8.
3
[Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].[杂聚糖病和鞘脂贮积症中的表型(作者译)]
Monatsschr Kinderheilkd. 1981 Nov;129(11):610-20.
4
Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.特定溶酶体贮积病的肺部受累及酶替代治疗的影响:一篇综述。
Clin Respir J. 2020 May;14(5):422-429. doi: 10.1111/crj.13150. Epub 2020 Jan 22.
5
Patients' perspectives on newborn screening for later-onset lysosomal storage diseases.患者对迟发性溶酶体贮积症新生儿筛查的看法。
Mol Genet Metab. 2016 Sep;119(1-2):109-14. doi: 10.1016/j.ymgme.2016.07.009. Epub 2016 Jul 21.
6
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.多种溶酶体贮积症内吞途径改变的比较研究
Mol Pharm. 2016 Feb 1;13(2):357-368. doi: 10.1021/acs.molpharmaceut.5b00542. Epub 2016 Jan 11.
7
Lysosomal storage diseases.溶酶体贮积症。
Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4.
8
[Lysosomal storage diseases].[溶酶体贮积症]
Z Rheumatol. 2010 Aug;69(6):527-38. doi: 10.1007/s00393-010-0627-z.
9
Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases.在遗传性溶酶体疾病的实验室诊断中,培养细胞中甲胺的积累作为水性储存区室的一种衡量指标。
Am J Med Genet. 1996 May 3;63(1):198-202. doi: 10.1002/(SICI)1096-8628(19960503)63:1<198::AID-AJMG35>3.0.CO;2-H.
10
Lysosomal storage diseases in Greece.希腊的溶酶体贮积症
Genet Couns. 1995;6(1):43-7.

引用本文的文献

1
Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).拉罗尼酶的安全性评估:基于美国食品药品监督管理局不良事件报告系统(FAERS)的真实世界不良事件分析
Front Pharmacol. 2025 Aug 20;16:1623921. doi: 10.3389/fphar.2025.1623921. eCollection 2025.
2
The first case of sick sinus syndrome with an adult Sanfilippo A syndrome: a case report with review of literature.首例患有成人Sanfilippo A综合征的病态窦房结综合征:病例报告并文献复习
BMC Neurol. 2025 Aug 13;25(1):330. doi: 10.1186/s12883-025-04354-7.
3
Analysis of the Effect of Demographic Variables on Lysosomal Enzyme Activities in the Missouri Newborn Screening Program.

本文引用的文献

1
[Clinical and molecular characteristics of a child with juvenile Sandhoff disease].[一名少年型桑德霍夫病患儿的临床和分子特征]
Zhonghua Er Ke Za Zhi. 2014 Apr;52(4):313-6.
2
Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.黏多糖贮积症 II 型:在拉丁美洲患者中鉴定出 30 种新突变。
Mol Genet Metab. 2014 Feb;111(2):133-8. doi: 10.1016/j.ymgme.2013.08.011. Epub 2013 Sep 1.
3
[Analysis of GALNS gene mutation in thirty-eight Chinese patients with mucopolysaccharidosis type IVA].[38例中国IVA型黏多糖贮积症患者GALNS基因突变分析]
密苏里州新生儿筛查项目中人口统计学变量对溶酶体酶活性影响的分析
Int J Neonatal Screen. 2025 Jun 19;11(2):48. doi: 10.3390/ijns11020048.
4
The Birth Prevalence of Mucopolysaccharidosis Types I, II, III, IVA, VI, and VII in the Republic of Kazakhstan Between 1984 and 2023.1984年至2023年哈萨克斯坦共和国I型、II型、III型、IVA 型、VI型和VII型黏多糖贮积症的出生患病率
Diagnostics (Basel). 2025 Mar 10;15(6):679. doi: 10.3390/diagnostics15060679.
5
Epidemiology of Mucopolysaccharidosis Type II According to the Register of the Russian Federation.根据俄罗斯联邦登记册统计的II型黏多糖贮积症流行病学情况。
Turk Arch Pediatr. 2025 Jan 2;60(1):41-47. doi: 10.5152/TurkArchPediatr.2025.24158.
6
A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II.关于黏多糖贮积症II型新生儿筛查全球现状的系统文献综述
Int J Neonatal Screen. 2024 Oct 10;10(4):71. doi: 10.3390/ijns10040071.
7
Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China.中国黏多糖贮积症患者的卫生服务利用、经济负担和生活质量。
Orphanet J Rare Dis. 2024 Sep 6;19(1):324. doi: 10.1186/s13023-024-03333-4.
8
Newborn Screening for 6 Lysosomal Storage Disorders in China.中国新生儿 6 种溶酶体贮积症的筛查。
JAMA Netw Open. 2024 May 1;7(5):e2410754. doi: 10.1001/jamanetworkopen.2024.10754.
9
Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses.串联质谱在黏多糖贮积症的筛查和诊断中的应用。
Orphanet J Rare Dis. 2024 Apr 29;19(1):179. doi: 10.1186/s13023-024-03195-w.
10
Curated incidence of lysosomal storage diseases from the Taiwan Biobank.台湾生物银行中溶酶体贮积症的整理发病率。
NPJ Genom Med. 2023 Sep 23;8(1):27. doi: 10.1038/s41525-023-00372-x.
Zhonghua Er Ke Za Zhi. 2013 Jun;51(6):414-9.
4
Molecular genetic assay of mucopolysaccharidosis IVA in South China.华南地区黏多糖贮积症 IVA 的分子遗传学检测。
Gene. 2013 Dec 10;532(1):46-52. doi: 10.1016/j.gene.2013.08.097. Epub 2013 Sep 11.
5
Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease.鉴定中国酸性鞘磷脂酶缺乏型尼曼-匹克病患者 SMPD1 基因突变谱。
Orphanet J Rare Dis. 2013 Jan 28;8:15. doi: 10.1186/1750-1172-8-15.
6
[Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis].52例黏多糖贮积症患儿的酶学诊断及临床特征
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jul;14(7):510-4.
7
Analysis of the IDS gene in 38 patients with Hunter syndrome: the c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing.对 38 名亨特综合征患者的 IDS 基因进行分析:女性个体中的 c.879G>A(p.Gln293Gln)同义变异导致外显子剪接。
PLoS One. 2011;6(8):e22951. doi: 10.1371/journal.pone.0022951. Epub 2011 Aug 4.
8
Mucopolysaccharidosis IVA mutations in Chinese patients: 16 novel mutations.中国患者的黏多糖贮积症 IVA 突变:16 个新突变。
J Hum Genet. 2010 Aug;55(8):534-40. doi: 10.1038/jhg.2010.65. Epub 2010 Jun 24.
9
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.捷克共和国溶酶体贮积症的出生患病率:与不同人群数据的比较。
J Inherit Metab Dis. 2010 Aug;33(4):387-96. doi: 10.1007/s10545-010-9093-7. Epub 2010 May 20.
10
[Establishment and clinical application of dried blood spots and mixed leukocytes for determination of acid alpha-glucosidase activity].[用于测定酸性α-葡萄糖苷酶活性的干血斑和混合白细胞的建立及临床应用]
Zhonghua Er Ke Za Zhi. 2010 Jan;48(1):55-9.